Skip to content
AnalystLens

UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2015

Filing Date
Filed February 9, 2016
Period End
December 31, 2015
Security
UNH
One revenue dollarkept$0.04
In the record · 2016–202610-K1110-Q328-K173

UNH filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 173 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Feb ’22Feb ’22
  2. Leadership change8-K · Mar ’26Mar ’26

Summary

Summary of the 10-K filed February 9, 2016. Cited figures are marked; the original filing is the authoritative source.

UnitedHealth Group Inc. (UNH) demonstrated strong revenue growth in 2015, with consolidated revenues increasing by 20% to $157.1 billiona, largely driven by the significant acquisition of Catamaran Corporation, which bolstered the OptumRx segment.

The company also saw a 10% increase in UnitedHealthcare revenues, reflecting growth in people served and price increases. Earnings from operations saw a 7% rise, with Optum demonstrating robust growth of 30%, partially offset by a 3% decrease in UnitedHealthcare earnings. Diluted earnings per share improved by 5% to $6.01b, and cash flow from operations increased by 21% to $9.7 billion.

The company's diversified business model, with its two platforms, UnitedHealthcare (providing health benefits) and Optum (providing health services), continues to drive performance. UnitedHealthcare experienced growth across Medicare & Retirement, Community & State, and Employer & Individual segments, though Global operations saw a decline. Optum's segments, particularly OptumRx due to the Catamaran acquisition and OptumHealth and OptumInsight through organic growth, all reported significant revenue and earnings increases.

Despite the positive financial trends, investors should note the company's ongoing engagement with regulatory changes, particularly related to the Affordable Care Act, and the impact of Medicare Advantage funding pressures. The company also incurred significant losses and established premium deficiency reserves for its individual exchange-compliant products. The company's strategic focus on expanding value-based care arrangements and leveraging its technology and data analytics capabilities through the Optum platform remain key drivers for future growth.

Key Highlights

  1. Consolidated revenues grew 20% to $157.1 billion in 2015, fueled by the acquisition of Catamaran and organic growth.
  2. The Optum segment revenue increased by 42%, with OptumRx seeing a 51% rise driven by the Catamaran acquisition.
  3. UnitedHealthcare revenue increased by 10%, with Medicare & Retirement, Community & State, and Employer & Individual segments showing growth.
  4. Earnings from operations rose 7% to $11.02 billion, with Optum earnings up 30% and UnitedHealthcare earnings down 3%.
  5. Diluted earnings per share increased by 5% to $6.01.
  6. Cash flow from operations increased by 21% to $9.7 billion.
  7. The company acquired Catamaran for $14.3 billion in cash, significantly expanding its pharmacy benefits management capabilities.

Follow one dollar

Of each $1.00 of revenue in FY2015, UnitedHealth Group Inc kept $0.04.

  1. Revenue$157.11B100.0%
  2. Cost of revenue−$16.21B10.3%
  3. Gross profit$140.90B89.7%
  4. Operating costs−$129.88B82.7%
  5. Operating income$11.02B7.0%
  6. Interest, other & tax−$5.21B3.3%
  7. Net income$5.81B3.7%
Computed from 10-KFY2015filed February 9, 2016Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2015 revenue went

$157.11B
  • Other operating costs: $105.57B, 67% of revenue
  • SG&A: $24.31B, 15% of revenue
  • Net income: $5.81B, 3.7% of revenue
  • Cost of revenue: $16.21B, 10% of revenue
  • Interest, other & tax: $5.21B, 3.3% of revenue

Kept 3.7% as net incomeNet income $5.81B · 3.7%

Full revenue history →

Financial Statements

FY2015 against FY2014

Line itemFY2015FY2014Change
Revenue$157.11B$130.47B+20.4%
Cost of Revenue$16.21B$3.83B+323.6%
Gross Profit$140.90B$126.65B+11.3%
SG&A Expenses$24.31B$21.26B+14.3%
Operating Expenses$146.09B$120.20B+21.5%
Operating Income$11.02B$10.27B+7.3%
Interest Expense$790.00M$618.00M+27.8%
Net Income$5.81B$5.62B+3.5%
EPS (Basic)$6.10$5.78+5.5%
EPS (Diluted)$6.01$5.70+5.4%
Shares Outstanding (Basic)953.00M972.00M−2.0%
Shares Outstanding (Diluted)967.00M986.00M−1.9%

Frequently Asked Questions

  1. What was the main driver of UnitedHealth Group's revenue growth in 2015?

    The primary driver of UnitedHealth Group's revenue growth in 2015 was the acquisition of Catamaran Corporation in July 2015, which significantly expanded its OptumRx segment. Organic growth across various UnitedHealthcare and other Optum businesses also contributed to the overall 20% revenue increase.

  2. How did the company's two main platforms, UnitedHealthcare and Optum, perform in 2015?

    UnitedHealthcare saw a 10% revenue increase, driven by growth in its Medicare & Retirement, Community & State, and Employer & Individual segments. The Optum platform experienced a substantial 42% revenue increase, with OptumRx benefiting greatly from the Catamaran acquisition and OptumHealth and OptumInsight showing strong double-digit growth due to organic expansion and acquisitions.

  3. What are the key challenges or risks highlighted by the company in its 2015 10-K filing?

    Key challenges and risks mentioned include potential medical cost inflation and utilization increases impacting profitability of risk-based products, regulatory changes and uncertainties (especially around Medicare Advantage funding and the Affordable Care Act), increasing competition, and the need to manage large amounts of data securely. The company also noted significant losses and premium deficiency reserves related to individual exchange-compliant products.

  4. What is the significance of the Catamaran acquisition?

    The acquisition of Catamaran for $14.3 billion significantly enhanced OptumRx's capabilities in pharmacy benefits management. It diversified OptumRx's customer and business mix, strengthened its technology platform, and expanded its reach, making it a more comprehensive provider in the pharmacy services market.